[Pseudomonas aeruginosa and hospital-acquired infections]

J Raymond1

  • 1Service de bactériologie, hôpital Cochin, 27, rue du Faubourg-Saint-Jacques, 75679 Parisx 14, France. j.raymond@svp.ap-hop-paris.fr

Insights

Pseudomonas aeruginosa causes 10% of hospital infections in children and adults. Preventing infections requires adequate antibiotic use, as fluoroquinolones can promote dangerous multiresistant strains.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Hospital Epidemiology

Context:

  • Pseudomonas aeruginosa is a significant pathogen responsible for 10% of hospital-acquired infections (HAIs) in both pediatric and adult populations.
  • Colonization by P. aeruginosa can originate from endogenous sources or exogenous environments, including water systems and healthcare worker hand carriage.
  • The increasing prevalence of healthcare-associated infections underscores the need to understand transmission dynamics and prevention strategies.

Purpose:

  • To highlight the role of Pseudomonas aeruginosa in hospital-acquired infections.
  • To identify key factors contributing to P. aeruginosa colonization and transmission within healthcare settings.
  • To emphasize the critical importance of appropriate antibiotic stewardship in preventing the emergence of multidrug-resistant P. aeruginosa.

Summary:

  • Pseudomonas aeruginosa accounts for a substantial proportion of HAIs, affecting patients of all ages.
  • Environmental contamination and healthcare personnel are significant reservoirs for P. aeruginosa transmission.
  • Judicious antibiotic selection is paramount; fluoroquinolone use is identified as a primary risk factor for selecting multidrug-resistant strains.

Impact:

  • Informing infection control protocols to mitigate P. aeruginosa spread in hospitals.
  • Guiding antibiotic prescribing practices to preserve treatment efficacy and combat antimicrobial resistance.
  • Reducing the burden of HAIs caused by this opportunistic pathogen.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...